Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

A new study from Geneva has found that adults with Attention Deficit Hyperactivity Disorder (ADHD) may be more likely to ...